Turn on desktop notifications for breaking stories about interest?
OffOn
Indonesia green-lights emergency use of Chinese vaccine
Indonesia s Food and Drug Authority has authorized emergency use of the COVID-19 vaccine produced by China-based Sinovac Biotech Ltd
By VICTORIA MILKO and EDNA TARIGAN Associated Press
January 11, 2021, 9:24 AM
• 3 min read
Catch up on the developing stories making headlines.The Associated Press
JAKARTA, Indonesia Indonesia’s Food and Drug Authority on Monday green-lighted emergency use of the COVID-19 vaccine produced by China-based Sinovac Biotech Ltd., with vaccinations of high-risk groups expected to start later this week.
Conditional vaccination of healthcare workers and other civil servants using the vaccine, called CoronaVac, is expected to begin this week.
Despite Bolsonaro Objection, China in Running to Provide Vaccine to Brazil
NEW DELHI Competing Brazilian politicians have ended up inviting both China’s Sinovac and India’s Serum Institute for COVID-19 vaccines amid delays in the production of Brazil’s own vaccine.
Meanwhile, the country’s private clinics have turned to another Indian vaccine producer, Bharat Biotech, for 5 million doses of its COVID-19 vaccine called Covaxin.
Brazil has the third-highest cases of CCP virus, but, despite having the capacity to produce the vaccine, the country’s administration couldn’t achieve the timely production of a home-made vaccine.
President Jair Bolsonaro’s rival and contender in the 2022 presidential race, the governor of Sao Paulo, Joao Doria, invited China’s Sinovac to supply its Coronavac vaccine for the 44 million residents of his province.
SAO PAULO (AP) A vaccine candidate made by China’s Sinovac is 78% effective in protecting against the coronavirus, according to results of a study announced Thursday by Brazilian state health.